Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$611.32K

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 7, 2026
Public filing date Jul 8, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$563.7 Jul 7, 2026
First close after public filing
$552.48 Jul 9, 2026
30-day return after filing
-2.47% Through Aug 7, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
1,096 shares @ $557.78
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000093
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.6M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jul 7, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 7, 2026 $331.08K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $110.62K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $133.6K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $404.06K
United Therapeutics Corp UTHR Current Sale Jul 7, 2026 $611.32K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $1.05M
United Therapeutics Corp UTHR Sale Jul 7, 2026 $1.9M
United Therapeutics Corp UTHR Sale Jul 7, 2026 $283.05K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $450.08K
United Therapeutics Corp UTHR Sale Jul 7, 2026 $34.92K
United Therapeutics Corp UTHR Exercise Jul 7, 2026 $0